Biography and Research Information
OverviewAI-generated summary
Pritam Biswas's research focuses on the molecular mechanisms underlying cellular apoptosis, particularly in the context of cancer, and the potential of nanomaterials in therapeutic applications. His work investigates the role of specific lipid mediators and cytokines, such as IL-13 and 13(S)HpODE, in initiating apoptotic pathways through signaling cascades involving MAO-A, ROS, and p53/p21. Biswas also explores the application of redox nanomedicine for conditions like chronic kidney disease, aiming to recondition mitochondria. His research has involved preclinical animal studies to assess the safety and efficacy of nanomaterials, including their redox buffering capacity in relation to ROS-based therapeutics and toxicity. He has co-authored publications with researchers at the University of Arkansas for Medical Sciences, including Samrat Roy Choudhury and Akhilesh Kaushal. Biswas has an h-index of 15 and has authored 85 publications with 745 citations.
Metrics
- h-index: 15
- Publications: 85
- Citations: 745
Selected Publications
-
Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia (2025)
-
Abstract 2281 Epigenetic Drivers and Subtype-Specific Roles of DNMT3B in Acute Myeloid Leukemia (2025)
-
Abstract P16: CBFA2T3-GLIS2 fusion leads to a distinct DNA methylation enhancer landscape in pediatric acute myeloid leukemia (2024)
Collaboration Network
Top Collaborators
Samir Kumar Pal
S.N. Bose National Centre for Basic Sciences (IN)
11 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A Combined Spectroscopic and Theoretical Analysis of Plasmonic Silver Nanoparticle Sensor Towards Detailed Microscopic Understanding of Heavy Metal Detection
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
Showing 5 of 11 shared publications
Aniruddha Adhikari
S.N. Bose National Centre for Basic Sciences (IN)
10 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
Showing 5 of 10 shared publications
Susmita Mondal
S.N. Bose National Centre for Basic Sciences (IN)
10 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
Showing 5 of 10 shared publications
Ria Ghosh
S.N. Bose National Centre for Basic Sciences (IN)
7 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
- A combined spectroscopic and molecular modeling Study on structure-function-dynamics under chemical modification: Alpha-chymotrypsin with formalin preservative
Showing 5 of 7 shared publications
Soumendra Darbar
6 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-based Therapeutics and Toxicity: A Preclinical Animal Study
Showing 5 of 6 shared publications
Uttam Pal
6 shared publications
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
- A combined spectroscopic and molecular modeling Study on structure-function-dynamics under chemical modification: Alpha-chymotrypsin with formalin preservative
- Essential Loop Dynamics Modulates Catalytic Activity in α-Chymotrypsin
- A Combined Spectroscopic and Molecular Modeling Study on Structure-Function-Dynamics under Chemical Modification: Alpha-Chymotrypsin with Formalin Preservative
Showing 5 of 6 shared publications
Monojit Das
Vidyasagar University (IN)
5 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-based Therapeutics and Toxicity: A Preclinical Animal Study
- Redox Nanomedicine Cures Chronic Kidney Disease (CKD) by Mitochondrial Reconditioning
Anjan Kumar Das
Government Medical College and Hospital (IN)
5 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-based Therapeutics and Toxicity: A Preclinical Animal Study
- Redox Nanomedicine Cures Chronic Kidney Disease (CKD) by Mitochondrial Reconditioning
Saleh A. Ahmed
Umm al-Qura University (SA)
5 shared publications
- Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- Paper-based plasmonic nanosensor monitors environmental lead pollution in real field
- A combined spectroscopic and molecular modeling Study on structure-function-dynamics under chemical modification: Alpha-chymotrypsin with formalin preservative
- Redox Nanomedicine Cures Chronic Kidney Disease (CKD) by Mitochondrial Reconditioning
Dipanjan Mukherjee
S.N. Bose National Centre for Basic Sciences (IN)
5 shared publications
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
- A combined spectroscopic and molecular modeling Study on structure-function-dynamics under chemical modification: Alpha-chymotrypsin with formalin preservative
- Essential Loop Dynamics Modulates Catalytic Activity in α-Chymotrypsin
- A Combined Spectroscopic and Molecular Modeling Study on Structure-Function-Dynamics under Chemical Modification: Alpha-Chymotrypsin with Formalin Preservative
Soumendra Singh
S.N. Bose National Centre for Basic Sciences (IN)
4 shared publications
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Paper-based plasmonic nanosensor monitors environmental lead pollution in real field
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-based Therapeutics and Toxicity: A Preclinical Animal Study
Tanusri Saha‐Dasgupta
S.N. Bose National Centre for Basic Sciences (IN)
4 shared publications
- In vitro and Microbiological Assay of Functionalized Hybrid Nanomaterials To Validate Their Efficacy in Nanotheranostics: A Combined Spectroscopic and Computational Study
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
- Essential Loop Dynamics Modulates Catalytic Activity in α-Chymotrypsin
- A Combined Spectroscopic and Molecular Modeling Study on Structure-Function-Dynamics under Chemical Modification: Alpha-Chymotrypsin with Formalin Preservative
Ranjan Das
West Bengal State University (IN)
4 shared publications
- Essential Loop Dynamics Modulates Catalytic Activity in α‐Chymotrypsin
- A combined spectroscopic and molecular modeling Study on structure-function-dynamics under chemical modification: Alpha-chymotrypsin with formalin preservative
- Essential Loop Dynamics Modulates Catalytic Activity in α-Chymotrypsin
- A Combined Spectroscopic and Molecular Modeling Study on Structure-Function-Dynamics under Chemical Modification: Alpha-Chymotrypsin with Formalin Preservative
Samrat Roy Choudhury
Arkansas Children's Hospital
4 shared publications
In database
- Abstract P16: CBFA2T3-GLIS2 fusion leads to a distinct DNA methylation enhancer landscape in pediatric acute myeloid leukemia
- Abstract 2281 Epigenetic Drivers and Subtype-Specific Roles of DNMT3B in Acute Myeloid Leukemia
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
- DNMT3B Controls Enhancer-Linked Chromatin and Cell Cycle Networks in Acute Myeloid Leukemia
Siddhartha Bhattacharya
University of Calcutta (IN)
3 shared publications
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-Based Therapeutics and Toxicity: A Preclinical Animal Study
- A nano erythropoiesis stimulating agent for the treatment of anemia and associated disorders
- Redox Buffering Capacity of Nanomaterials as an Index of ROS-based Therapeutics and Toxicity: A Preclinical Animal Study
Similar Researchers
Based on overlapping research topics
Jackson Gill
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Mitochondrial Function and Pathology
Disease Mechanisms Research
Gretchen Holtgrefe
University of Arkansas for Medical Sciences
Nanoparticles: synthesis and applications
Disease Mechanisms Research
Pharmacological Effects and Toxicity Studies
Alexei G. Basnakian
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Nanoparticles: synthesis and applications
Mitochondrial Function and Pathology
Jessica Hawes Oliphant
National Center for Toxicological Research
Mitochondrial Function and Pathology
Disease Mechanisms Research
Pharmacological Effects and Toxicity Studies
Nukhet Aykin-Burns
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Mitochondrial Function and Pathology
Disease Mechanisms Research
K. Gokulan
National Center for Toxicological Research
Nanoparticles: synthesis and applications
Disease Mechanisms Research
Pharmacological Effects and Toxicity Studies